about
Genetic variants of SOX9 contribute to susceptibility of gliomas among Chinese populationUpregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathwaySOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage.Sox9 transcriptionally regulates Wnt signaling in intestinal epithelial stem cells in hypomethylated crypts in the diabetic stateRevisiting the role of Wnt/β-catenin signaling in prostate cancer.Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate CancerUp-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9.MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway.miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.WNT signalling in prostate cancer.Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.MicroRNA-105 targets SOX9 and inhibits human glioma cell progression.Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction.Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.Transcription factor profiling identifies Sox9 as regulator of proliferation and differentiation in corneal epithelial stem/progenitor cells.
P2860
Q29248392-7518DE24-FD88-4191-A858-D1AE82FC334AQ33566676-A174CDBB-6363-4AEB-AE9E-B7DB9F3BDD46Q37336985-76EF4871-A7A6-4C1C-BDAC-0BCC4F88EDB7Q37692443-BBA233A7-70AB-449F-B45F-484B2E96FD93Q39131794-91390CA4-347E-4675-9CED-0B8DEE8580E8Q39164084-CB1B8B11-068F-4D49-96FA-C436B60104C4Q41478244-FCE19B0F-1CD9-4BA2-A4DE-41A8F2552187Q41491922-B7D21548-2B19-4FAE-BCF3-E0F7CE11A7ECQ47095936-84331272-D86B-44A5-862D-09B21BC0C2B5Q47127087-8BB0BAAB-FF64-4C46-B8A4-5936DF53B791Q47401320-2F30F369-FF58-488D-9F8B-A1C026582921Q47818549-669364BB-FCE7-4FE7-A401-DD8ECF35F583Q48020980-486E67D1-C9EC-4C65-B7EE-701C3C10D6B2Q48480092-EFFC5BA2-7A29-4ABC-BD2B-1C79C5F7F447Q49246888-832121AE-8374-41AC-860E-18B938AE0626Q49263865-C3D228CD-3A7E-4F9D-9C84-4AAB1359A935Q49875087-D5362061-08B2-458F-A184-7DD3572B75BDQ52764125-D3AD3387-08BA-4F4A-9898-F6F727433BA7Q55642025-771F398A-4634-412B-B529-F2763628D4BD
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
SOX9 drives WNT pathway activation in prostate cancer.
@en
type
label
SOX9 drives WNT pathway activation in prostate cancer.
@en
prefLabel
SOX9 drives WNT pathway activation in prostate cancer.
@en
P2093
P2860
P356
P1476
SOX9 drives WNT pathway activation in prostate cancer.
@en
P2093
Benjamin A Tanenbaum
Hongyun Wang
Housheng Hansen He
Lingfeng He
Sean J Gerrin
Steven P Balk
P2860
P304
P356
10.1172/JCI78815
P407
P577
2016-04-04T00:00:00Z